Next year, the UK will conclude its transition  from the EU, with the regulation of all medicines and devices to be transferred from EMEA to the UK's Medicines and Healthcare products Regulatory Agency (MHRA).  This new regime will apply from 01 January 2021, and will...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags